Medherant Limited

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Company Changes AGARWAL , Sunil, MD To: Juno Therapeutics Inc. , Pres., R&D (April) From: Ultragenyx Pharmaceutical Inc., EVP, CMO Phone: 206-582-1600 AL-WAKEEL Yasir To: Neon Therapeutics

Medherant Ltd. The Venture Centre University of Warwick Science Park Coventry, CV4 7EZ, UK Phone: +44 7711 983344 Web Site: www.medherant.co.uk Contact: Nigel Davis, PhD, CEO Industry Segment

IN VITRO DIAGNOSTICS Mergers & Acquisitions Opko Health Inc. Bio-Reference Laboratories Inc. Opko Health Inc. acquired publicly traded Bio-Reference Laboratories Inc. (BRLI; clinical laborator